Top Buy
| Wertpapier | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Evotec SE | 10 | 1 | 3 | 0 | 5,93 € | 7,00 € | 18,04 % |
| Alnylam Pharmace. | 48 | 1 | 3 | 1 | 226,60 € | 270,99 € | 19,59 % |
| Arrowhead Pharmaceuticals Inc. | 20 | 2 | 2 | 0 | 19,99 € | 54,98 € | 175,11 % |
| PTC Therapeutics Inc. | 17 | 9 | 2 | 0 | 28,00 € | 41,46 € | 48,08 % |
| Emergent Biosolutions Inc. | 9 | 2 | 2 | 0 | 6,70 € | 7,44 € | 11,07 % |
| Amicus Therapeutics Inc. | 9 | 0 | 1 | 0 | 10,30 € | 17,63 € | 71,18 % |
| Taro Pharmaceutical Industries Ltd | 9 | 0 | 0 | 0 | 40,00 € | - | - |
| Icon plc | 24 | 0 | 0 | 0 | 282,90 € | 324,79 € | 14,81 % |
| QIAGEN NV | 12 | 0 | 0 | 0 | 40,47 € | 47,52 € | 17,42 % |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 0 | 0 | 43,01 € | 56,72 € | 31,88 % |
| United Therapeutics | 27 | 1 | 0 | 0 | 316,50 € | 315,21 € | -0,41 % |
| Charles River Labs Intl | 13 | 0 | 0 | 0 | 172,10 € | 247,61 € | 43,87 % |
| Exelixis Inc. | 21 | 0 | 0 | 0 | 23,05 € | 26,01 € | 12,83 % |
| Neurocrine Bioscience | 44 | 0 | 0 | 0 | 108,30 € | 149,47 € | 38,02 % |
| Catalent Inc. | 1 | 0 | 0 | 0 | 54,00 € | 55,00 € | 1,85 % |
| Hutchison China MediTech Ltd ADR | 3 | 0 | 0 | 0 | 16,00 € | 20,23 € | 26,44 % |
| Acadia Pharmaceuticals | 35 | 1 | 0 | 0 | 14,62 € | 29,92 € | 104,62 % |
| Repligen Corp. | 15 | 0 | 0 | 0 | 130,75 € | 178,01 € | 36,15 % |
| Iovance Biotherapeutics Inc. | 20 | 1 | 0 | 0 | 8,87 € | 25,72 € | 189,89 % |
| MorphoSys AG | 7 | 0 | 0 | 0 | 67,40 € | 65,00 € | -3,56 % |
| Dr. Reddy's Laboratories Ltd. ADR | 7 | 1 | 0 | 0 | 71,00 € | 75,37 € | 6,16 % |
| Novocure Ltd | 1 | 0 | 0 | 0 | 15,08 € | - | - |
| Nektar Therapeutics | 4 | 1 | 0 | 0 | 1,03 € | 2,40 € | 133,69 % |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | 25,38 € | 35,01 € | 37,92 % |
| Bausch Health Companies Inc. | 6 | 0 | 0 | 0 | 5,58 € | 12,95 € | 132,05 % |